Citigroup
GBT

Citigroup’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Citigroup’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-17,700
Closed -$767K – 7721
2020
Q4 		$767K Buy
17,700
+300
+2% +$14.8K ﹤0.01% 3811
2020
Q3 		$959K Sell
17,400
-2,000
-10% -$127K ﹤0.01% 3310
2020
Q2 		$1.23M Sell
19,400
-6,800
-26% -$466K ﹤0.01% 3336
2020
Q1 		$1.34M Sell
26,200
-6,900
-21% -$462K ﹤0.01% 2873
2019
Q4 		$2.63M Buy
33,100
+7,700
+30% +$456K ﹤0.01% 2699
2019
Q3 		$1.23M Sell
25,400
-5,300
-17% -$276K ﹤0.01% 3405
2019
Q2 		$1.61M Buy
30,700
+18,700
+156% +$1.07M ﹤0.01% 3095
2019
Q1 		$635K Sell
12,000
-700
-6% -$34.4K ﹤0.01% 3924
2018
Q4 		$521K Sell
12,700
-100
-0.8% -$3.75K ﹤0.01% 4087
2018
Q3 		$486K Sell
12,800
-13,600
-52% -$602K ﹤0.01% 4315
2018
Q2 		$1.19M Buy
26,400
+18,700
+243% +$851K ﹤0.01% 3168
2018
Q1 		$372K Sell
7,700
-4,300
-36% -$240K ﹤0.01% 4297
2017
Q4 		$472K Buy
12,000
+3,800
+46% +$142K ﹤0.01% 4156
2017
Q3 		$255K Buy
+8,200
New +$231K ﹤0.01% 4777
2017
Q2 		– Sell
-1,500
Closed -$55K – 7546
2017
Q1 		$55K Buy
1,500
+600
+67% +$15.1K ﹤0.01% 5632
2016
Q4 		$13K Buy
+900
New +$15.8K ﹤0.01% 6681

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citigroup's GBT Position: Q4 2022 in Review

Citigroup sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 1,586,334 shares — an estimated $108M sold.

Citigroup first reported a position in GBT in Q3 2015 and held it in 29 quarters. The position peaked at $108M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Citigroup reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Citigroup sold 1,586,334 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $108M.
  • Citigroup first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 29 quarters.
  • Citigroup's Global Blood Therapeutics, Inc. position peaked at $108M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.